
LeucineOS
Pharmaceutical SaaS
Funding Raised
$7M
Series A
Directed the AI-native LeucineOS launch end-to-end, influencing $200K+ in paid pilots and custom deployments while building a $120K+/year pipeline and sustaining 100% enterprise renewals. Rolled out AI investigation and document workflows to 20+ pharma plants (Amneal, Cipla, Dr. Reddy's, Piramal, Sun Pharma, Teva), unlocking 20%+ efficiency gains and 35% faster operations while positioning LeucineOS as a specialized Palantir alternative. Co-architected ontology-driven models plus PostgreSQL, Supabase, and React surfaces, shepherding InfoSec, VAPT, and cloud reviews to unblock enterprise go-lives.





.svg.png&w=3840&q=75)









